These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 6592471

  • 1. [Synchronization chemoradiotherapy for malignant gliomas].
    Yamamoto H, Sato F, Nakamura O, Kohno T, Shitara N, Takakura K, Sano K, Maehara T, Akanuma A.
    No Shinkei Geka; 1984 Jun; 12(7):795-805. PubMed ID: 6592471
    [Abstract] [Full Text] [Related]

  • 2. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M, Müller B, Koch R, Bamberg M, Krauseneck P, Neuro-Oncology Working Group of the German Cancer Society.
    J Clin Oncol; 2003 Sep 01; 21(17):3276-84. PubMed ID: 12947063
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
    Ushio Y, Abe H, Suzuki J, Tanaka R, Kitamura K, Miwa T, Matsutani M, Takeuchi K, Takakura K, Nomura K.
    No To Shinkei; 1985 Oct 01; 37(10):999-1006. PubMed ID: 3000412
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of radiation immunochemotherapy in the treatment of malignant glioma. Combined use of ACNU, VCR and PS-K].
    Kaneko S, Abe H, Aida T, Tokuda K, Tsuru M, Kitaoka K, Sato M, Iwakuma T, Ueno K, Kashiwaba T.
    Hokkaido Igaku Zasshi; 1983 Nov 01; 58(6):622-30. PubMed ID: 6584394
    [Abstract] [Full Text] [Related]

  • 5. [Chemotherapy with ACNU and radiation therapy in malignant glioma in cerebral hemisphere of adult].
    Miyagami M, Tsubokawa T.
    Gan To Kagaku Ryoho; 1990 Aug 01; 17(8 Pt 1):1447-53. PubMed ID: 2117885
    [Abstract] [Full Text] [Related]

  • 6. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE, Tsujii H, Hasegawa A, Yanagi T, Takagi R, Kamada T, Tsuji H, Takakura K, Organizing Committee of the Central Nervous System Tumor Working Group.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):390-6. PubMed ID: 17459607
    [Abstract] [Full Text] [Related]

  • 7. [Combined postoperative radiotherapy and chemotherapy for malignant gliomas].
    Aida T, Sugimoto S, Tokuda K, Abe H, Ikoda T, Itoh T, Ueno K, Kashiwaba T, Kaneko S, Kawamoto T.
    Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):952-9. PubMed ID: 2167916
    [Abstract] [Full Text] [Related]

  • 8. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW.
    Clin Cancer Res; 2003 Mar 20; 9(3):981-90. PubMed ID: 12631596
    [Abstract] [Full Text] [Related]

  • 9. Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).
    Shibui S, Narita Y, Mizusawa J, Beppu T, Ogasawara K, Sawamura Y, Kobayashi H, Nishikawa R, Mishima K, Muragaki Y, Maruyama T, Kuratsu J, Nakamura H, Kochi M, Minamida Y, Yamaki T, Kumabe T, Tominaga T, Kayama T, Sakurada K, Nagane M, Kobayashi K, Nakamura H, Ito T, Yazaki T, Sasaki H, Tanaka K, Takahashi H, Asai A, Todo T, Wakabayashi T, Takahashi J, Takano S, Fujimaki T, Sumi M, Miyakita Y, Nakazato Y, Sato A, Fukuda H, Nomura K.
    Cancer Chemother Pharmacol; 2013 Feb 20; 71(2):511-21. PubMed ID: 23228988
    [Abstract] [Full Text] [Related]

  • 10. Hyperfractionated radiotherapy and multi-agent chemotherapy (procarbazine, ACNU and vincristine) for high-grade gliomas: a prospective study.
    Ogawa K, Yoshii Y, Toita T, Saito A, Kakinohana Y, Iraha S, Sugimoto K, Tsuchida Y, Tamaki W, Adachi G, Hyodo A, Murayama S.
    Anticancer Res; 2006 Feb 20; 26(3B):2457-62. PubMed ID: 16821632
    [Abstract] [Full Text] [Related]

  • 11. [Chemical modifiers in radiotherapy].
    Nagashima T, Takakura K.
    Gan No Rinsho; 1989 Sep 20; 35(11):1369-71. PubMed ID: 2681875
    [Abstract] [Full Text] [Related]

  • 12. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
    Glas M, Hundsberger T, Stuplich M, Wiewrodt D, Kurzwelly D, Nguyen-Huu B, Rasch K, Herrlinger U.
    Oncology; 2009 Sep 20; 76(3):184-9. PubMed ID: 19218824
    [Abstract] [Full Text] [Related]

  • 13. [A trial of ACNU and radiation therapy with sensitizing agents for malignant gliomas].
    Kawano H, Hayashi M, Satoh K, Ishii H, Nakatsugawa S, Ishii Y.
    No To Shinkei; 1989 Nov 20; 41(11):1071-5. PubMed ID: 2620008
    [Abstract] [Full Text] [Related]

  • 14. [A randomized trial of 3-drug combination chemotherapy in small cell lung cancer--CPA/ACNU/VCR vs ADR/ACNU/VCR].
    Furuse K.
    Gan To Kagaku Ryoho; 1985 Sep 20; 12(9):1844-9. PubMed ID: 2994577
    [Abstract] [Full Text] [Related]

  • 15. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD, Jeremic B, Weller M, Plasswilm L, Bamberg M.
    Strahlenther Onkol; 2003 Apr 20; 179(4):219-32. PubMed ID: 12707711
    [Abstract] [Full Text] [Related]

  • 16. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1147-52. PubMed ID: 15001257
    [Abstract] [Full Text] [Related]

  • 17. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S, Takakura K.
    Gan To Kagaku Ryoho; 1986 Jan 15; 13(1):11-7. PubMed ID: 3942392
    [Abstract] [Full Text] [Related]

  • 18. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
    Mizumatsu S, Matsumoto K, Maeda Y, Tamiya T, Furuta T, Ohmoto T.
    Gan To Kagaku Ryoho; 1998 Nov 15; 25(13):2055-60. PubMed ID: 9838907
    [Abstract] [Full Text] [Related]

  • 19. [Controlled multimodality treatment of brain stem gliomas].
    Kito A, Yoshida J, Kageyama N.
    No Shinkei Geka; 1987 Jul 15; 15(7):797-803. PubMed ID: 2823158
    [Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K, Kanaya H, Fujiyama Y, Kim P.
    Acta Neurochir (Wien); 2002 Dec 15; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.